Related Experiment Video
Updated: Mar 1, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent Manner
Kyle Lewis1,2,3, Leila Valanejad1, Ashley Cast1
1Department of Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Abstract:
Despite intensive investigations, mechanisms of liver cancer are not known. Here, we identified an important step of liver cancer, which is the neutralization of tumor suppressor activities of an RNA binding protein, CUGBP1. The translational activity of CUGBP1 is activated by dephosphorylation at Ser302. We generated CUGBP1-S302A knock-in mice and found that the reduction of translational activity of CUGBP1 causes development of a fatty liver phenotype in young S302A mice. Examination of liver cancer in diethylnitrosamine (DEN)-treated CUGBP1-S302A mice showed these mice develop much more severe liver cancer that is associated with elimination of the mutant CUGBP1. Searching for mechanisms of this elimination, we found that the oncoprotein gankyrin (Gank) preferentially binds to and triggers degradation of dephosphorylated CUGBP1 (de-ph-S302-CUGBP1) or S302A mutant CUGBP1. To test the role of Gank in degradation of CUGBP1, we generated mice with liver-specific deletion of Gank. In these mice, the tumor suppressor isoform of CUGBP1 is protected from Gank-mediated degradation. Consistent with reduction of CUGBP1 in animal models, CUGBP1 is reduced in patients with pediatric liver cancer. Thus, this work presents evidence that de-ph-S302-CUGBP1 is a tumor suppressor protein and that the Gank-UPS-mediated reduction of CUGBP1 is a key event in the development of liver cancer.
Insights
CUGBP1 dephosphorylation at Ser302 activates its translation, promoting liver cancer. Gankyrin targets this form for degradation, a key event in liver cancer development. This study reveals CUGBP1 as a crucial tumor suppressor.
Area of Science:
- Hepatology
- Molecular Biology
- Oncology
Background:
- Mechanisms underlying liver cancer remain incompletely understood.
- CUGBP1, an RNA binding protein, has identified tumor suppressor activities.
- Dephosphorylation at Ser302 activates CUGBP1's translational activity.
Purpose of the Study:
- To elucidate the role of CUGBP1 phosphorylation in liver cancer.
- To investigate the mechanism of CUGBP1 neutralization in liver tumorigenesis.
- To identify factors contributing to the reduction of CUGBP1 in liver cancer.
Main Methods:
- Generation of CUGBP1-S302A knock-in mice.
- Diethylnitrosamine (DEN) treatment to induce liver cancer.
- Investigation of gankyrin (Gank) binding and degradation pathways.
- Generation of mice with liver-specific deletion of Gank.
Main Results:
- Reduced translational activity of CUGBP1 leads to fatty liver in S302A mice.
- DEN-treated S302A mice exhibit more severe liver cancer with CUGBP1 elimination.
- Gank preferentially binds and degrades dephosphorylated or S302A mutant CUGBP1.
- Liver-specific Gank deletion protects CUGBP1 from degradation, reducing tumor suppressor loss.
Conclusions:
- Dephosphorylated CUGBP1 (de-ph-S302-CUGBP1) functions as a tumor suppressor.
- Gank-induced degradation of CUGBP1 via the ubiquitin-proteasome system (UPS) is critical for liver cancer development.
- Reduced CUGBP1 levels correlate with liver cancer in both animal models and human pediatric liver cancer patients.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
12:26Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Inhibition of Cdk Activity
Negative Regulator Molecules
GPCRs Regulate Adenylyl Cylase Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation